Atrás
También listada como
MTHRY
OTC
Rango del Día
$11.00
$11.00
Rango de 52 Semanas
$9.45
$15.25
Volumen
300
Promedio 50D / 200D
$12.02
/
$13.38
Cierre Anterior
$11.00
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (633 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 0.2 | 0.2 |
| P/B | 0.0 | 2.8 |
| ROE % | 11.1 | 3.7 |
| Net Margin % | 14.2 | 3.9 |
| Rev Growth 5Y % | 13.9 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$121.15
$118.16 – $126.68
|
515.24B | 1 |
| FY2029 |
$107.49
$104.83 – $112.39
|
472.04B | 1 |
| FY2028 |
$92.72
$90.43 – $96.95
|
430.08B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-04 | $21.85 | $0.18 | -99.2% |
| 2025-11-12 | $0.09 | $0.11 | +14.6% |
| 2025-08-06 | $0.12 | $0.12 | +4.5% |
| 2025-05-02 | $0.11 | $0.08 | -23.9% |
| 2025-02-10 | $0.13 | $0.14 | +11.7% |
| 2024-10-30 | $0.10 | $0.06 | -38.2% |
| 2024-07-26 | $0.09 | $0.10 | +10.8% |
| 2024-04-26 | $0.11 | $0.08 | -22.4% |
Dividend History
6 yr streakYield
0.01%
Payout Ratio
0.35%
Growth (3Y)
2.21%
Growth (5Y)
12.23%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 30, 2026 | — | $0.13 | 1.20% |
| Mar 31, 2025 | Jun 09, 2025 | $0.14 | 1.47% |
| Mar 28, 2024 | Jun 10, 2024 | $0.14 | 0.95% |
| Mar 30, 2023 | Jun 12, 2023 | $0.14 | 0.60% |
| Mar 30, 2022 | Jun 13, 2022 | $0.13 | 0.35% |
| Mar 30, 2021 | Jun 10, 2021 | $0.11 | 0.16% |
| Mar 30, 2020 | Jun 16, 2020 | $0.08 | 0.28% |
| Mar 27, 2019 | Jun 11, 2019 | $0.06 | 0.39% |
| Mar 28, 2018 | Jun 08, 2018 | $0.10 | 0.12% |
| Mar 29, 2017 | Jun 12, 2017 | $0.09 | 0.02% |
| Mar 29, 2016 | Jun 13, 2016 | $0.08 | 0.01% |
| Mar 27, 2015 | Jun 12, 2015 | $0.07 | 0.04% |
| Mar 27, 2014 | Jun 19, 2014 | $12.73 | 0.12% |
| Mar 27, 2013 | Jun 25, 2013 | $12.71 | 0.12% |
| Mar 28, 2012 | Jun 11, 2012 | $30.21 | 0.09% |
| Mar 29, 2011 | Jun 06, 2011 | $60.69 | 0.09% |
| Mar 29, 2010 | Jun 07, 2010 | $38.85 | 0.06% |
| Mar 26, 2009 | Jun 08, 2009 | $33.39 | 0.05% |
| Mar 26, 2008 | Jun 09, 2008 | $30.31 | 0.05% |
Puntos Clave
Revenue grew 13.91% annually over 5 years — strong growth
Earnings declined -10.57% over the past year
ROE of 11.09% — decent returns on equity
Debt/Equity of 0.06 — conservative balance sheet
Generating 42.75B in free cash flow
P/E of 0.18 — trading at a low valuation
Crecimiento
Revenue Growth (5Y)
13.91%
Revenue (1Y)19.26%
Earnings (1Y)-10.57%
FCF Growth (3Y)-7.10%
Calidad
Return on Equity
11.09%
ROIC11.72%
Net Margin14.21%
Op. Margin22.10%
Seguridad
Debt / Equity
0.06
Current Ratio2.96
Interest Coverage87.83
Valoración
P/E Ratio
0.18
Forward P/E0.15
P/B Ratio0.02
EV/EBITDA-1.64
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 19.26% | Revenue Growth (3Y) | 11.10% |
| Earnings Growth (1Y) | -10.57% | Earnings Growth (3Y) | -9.13% |
| Revenue Growth (5Y) | 13.91% | Earnings Growth (5Y) | 1.71% |
| Profitability | |||
| Revenue (TTM) | 284.90B | Net Income (TTM) | 40.48B |
| ROE | 11.09% | ROA | 6.96% |
| Gross Margin | 54.18% | Operating Margin | 22.10% |
| Net Margin | 14.21% | Free Cash Flow (TTM) | 42.75B |
| ROIC | 11.72% | FCF Growth (3Y) | -7.10% |
| Safety | |||
| Debt / Equity | 0.06 | Current Ratio | 2.96 |
| Interest Coverage | 87.83 | ||
| Dividends | |||
| Dividend Yield | 0.01% | Payout Ratio | 0.35% |
| Dividend Growth (3Y) | 2.21% | Dividend Growth (5Y) | 12.23% |
| Consecutive Div Years | 6 yrs | ||
| Valuation | |||
| P/E Ratio | 0.18 | Forward P/E | 0.15 |
| P/B Ratio | 0.02 | P/S Ratio | 0.03 |
| PEG Ratio | -2.24 | Forward PEG | N/A |
| EV/EBITDA | -1.64 | Fwd EV/EBITDA | -0.80 |
| Forward P/S | 0.02 | Fwd Earnings Yield | 666.67% |
| FCF Yield | 573.82% | ||
| Market Cap | 7.45B | Enterprise Value | -103.06B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 284.90B | 238.88B | 230.82B | 208.16B | 169.20B |
| Net Income | 40.48B | 45.27B | 49.03B | 63.85B | 37.82B |
| EPS (Diluted) | 59.60 | 66.63 | 72.17 | 93.98 | 55.68 |
| Gross Profit | 154.36B | 140.53B | 135.19B | 123.27B | 103.40B |
| Operating Income | 62.97B | 64.38B | 71.98B | 95.14B | 58.36B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 581.74B | 490.78B | 400.65B | 345.98B | 273.12B |
| Total Liabilities | 168.94B | 124.08B | 91.13B | 82.03B | 65.86B |
| Shareholders' Equity | 378.44B | 351.92B | 302.63B | 257.84B | 199.81B |
| Total Debt | 24.42B | 18.51B | 10.38B | 8.30B | 5.42B |
| Cash & Equivalents | 134.93B | 149.66B | 118.32B | 104.25B | 89.14B |
| Current Assets | 243.43B | 240.74B | 203.47B | 198.87B | 164.11B |
| Current Liabilities | 82.11B | 67.17B | 59.58B | 57.22B | 50.31B |
Puntuaciones de Estrategias
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
Actividad Reciente
Salió
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entró
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entró
Defensive Investing (Benjamin Graham)
Mar 24, 2026